Alector snags funding in founder's latest attack on Alzheimer's

Something about the brain is driving Arnon Rosenthal. Alector LLC, Rosenthal's latest venture zeroing in on a treatment for dementia and Alzheimer's disease, closed a Series A round aimed at prepping two drugs for human clinical trials within two years...